Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹3,033 Cr
up ₹62.4 Cr vs Jan 2026
- Stocks held
- 30
- unchanged
- Top 10 weight
- 65.9%
- of the portfolio in its ten largest
- Cash & debt
- 1.1%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 15
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In February 2026 it disclosed 30 stocks worth ₹3,033 Cr, up ₹62.4 Cr from Jan 2026. Its largest positions were Sun Pharmaceutical Industries Limited (8.8%), IPCA Laboratories Limited (8.6%), Cipla Limited (8.1%); the ten largest together made up 65.9% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 63.1% of its equity. Cash and debt stood at 1.1%. Compared with Jan 2026 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
92%
Top-10 weight is higher than 92% of peers
Breadth
13%
Holds more stocks than 13% of peers
Cash
14%
Holds more cash than 14% of peers
Holdings in February 2026
Download CSVEvery line the fund disclosed, with the change against Jan 2026. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 8.79%
- Δ weight
- up 0.55 pts
- Value
- ₹267 Cr
- Δ value
- up ₹21.8 Cr
- Status
- Added
- Weight
- 8.55%
- Δ weight
- up 0.15 pts
- Value
- ₹259 Cr
- Δ value
- up ₹9.9 Cr
- Status
- Added
- Weight
- 8.06%
- Δ weight
- down 0.02 pts
- Value
- ₹244 Cr
- Δ value
- up ₹4.4 Cr
- Status
- Added
- Weight
- 7.69%
- Δ weight
- up 0.15 pts
- Value
- ₹233 Cr
- Δ value
- up ₹9.4 Cr
- Status
- Added
- Weight
- 6.50%
- Δ weight
- up 0.55 pts
- Value
- ₹197 Cr
- Δ value
- up ₹20.3 Cr
- Status
- Added
- Weight
- 6.47%
- Δ weight
- down 0.72 pts
- Value
- ₹196 Cr
- Δ value
- down ₹17.3 Cr
- Status
- Trimmed
- Weight
- 5.90%
- Δ weight
- up 0.86 pts
- Value
- ₹179 Cr
- Δ value
- up ₹29.2 Cr
- Status
- Added
- Weight
- 5.53%
- Δ weight
- down 0.19 pts
- Value
- ₹168 Cr
- Δ value
- down ₹2.2 Cr
- Status
- Trimmed
- Weight
- 5.02%
- Δ weight
- up 0.46 pts
- Value
- ₹152 Cr
- Δ value
- up ₹16.8 Cr
- Status
- Added
- Weight
- 3.35%
- Δ weight
- down 0.42 pts
- Value
- ₹102 Cr
- Δ value
- down ₹10.3 Cr
- Status
- Trimmed
- Weight
- 3.35%
- Δ weight
- up 0.27 pts
- Value
- ₹102 Cr
- Δ value
- up ₹10 Cr
- Status
- Added
- Weight
- 3.10%
- Δ weight
- up 0.08 pts
- Value
- ₹94 Cr
- Δ value
- up ₹4.3 Cr
- Status
- Added
- Weight
- 3.04%
- Δ weight
- down 0.78 pts
- Value
- ₹92.1 Cr
- Δ value
- down ₹21.2 Cr
- Status
- Trimmed
- Weight
- 2.88%
- Δ weight
- down 0.14 pts
- Value
- ₹87.3 Cr
- Δ value
- down ₹2.3 Cr
- Status
- Trimmed
- Weight
- 2.83%
- Δ weight
- down 0.09 pts
- Value
- ₹86 Cr
- Δ value
- down ₹1 Cr
- Status
- Trimmed
- Weight
- 2.57%
- Δ weight
- down 0.27 pts
- Value
- ₹78.1 Cr
- Δ value
- down ₹6.4 Cr
- Status
- Trimmed
- Weight
- 2.16%
- Δ weight
- down 0.21 pts
- Value
- ₹65.4 Cr
- Δ value
- down ₹4.9 Cr
- Status
- Trimmed
- Weight
- 2.00%
- Δ weight
- up 0.06 pts
- Value
- ₹60.6 Cr
- Δ value
- up ₹3.1 Cr
- Status
- Added
- Weight
- 1.86%
- Δ weight
- down 0.05 pts
- Value
- ₹56.5 Cr
- Δ value
- down ₹32 L
- Status
- Trimmed
- Weight
- 1.51%
- Δ weight
- up 0.04 pts
- Value
- ₹45.9 Cr
- Δ value
- up ₹2.1 Cr
- Status
- Added
- Weight
- 1.24%
- Δ weight
- up 0.12 pts
- Value
- ₹37.7 Cr
- Δ value
- up ₹4.2 Cr
- Status
- Added
- Weight
- 1.10%
- Δ weight
- up 0.03 pts
- Value
- ₹33.4 Cr
- Δ value
- up ₹1.7 Cr
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 1.06%
- Δ weight
- down 0.11 pts
- Value
- ₹32.3 Cr
- Δ value
- down ₹2.5 Cr
- Status
- Trimmed
- Weight
- 1.03%
- Δ weight
- down 0.06 pts
- Value
- ₹31.3 Cr
- Δ value
- down ₹1.2 Cr
- Status
- Trimmed
- Weight
- 0.97%
- Δ weight
- down 0.10 pts
- Value
- ₹29.5 Cr
- Δ value
- down ₹2.4 Cr
- Status
- Trimmed
- Global X Funds - Global X Genomics & Biotechnology ETFFund units
- Weight
- 0.88%
- Δ weight
- down 0.03 pts
- Value
- ₹26.6 Cr
- Δ value
- down ₹29 L
- Status
- Trimmed
- Weight
- 0.69%
- Δ weight
- down 0.02 pts
- Value
- ₹21.1 Cr
- Δ value
- down ₹14 L
- Status
- Trimmed
- Weight
- 0.61%
- Δ weight
- up 0.03 pts
- Value
- ₹18.6 Cr
- Δ value
- up ₹1.3 Cr
- Status
- Added
- Weight
- 0.54%
- Δ weight
- up 0.02 pts
- Value
- ₹16.3 Cr
- Δ value
- up ₹93 L
- Status
- Added
- Weight
- 0.39%
- Δ weight
- down 0.04 pts
- Value
- ₹11.9 Cr
- Δ value
- down ₹84 L
- Status
- Trimmed
- Weight
- 0.18%
- Δ weight
- down <0.01 pts
- Value
- ₹5.4 Cr
- Δ value
- up ₹10 L
- Status
- Added
- Weight
- 0.14%
- Δ weight
- down 0.12 pts
- Value
- ₹4.2 Cr
- Δ value
- down ₹3.6 Cr
- Status
- Trimmed
What changed, Jan 2026 to Feb 2026
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Sai Life Sciences Limitedup ₹29.2 Cr (+0.86% pts)
- Sun Pharmaceutical Industries Limitedup ₹21.8 Cr (+0.55% pts)
- Laurus Labs Limitedup ₹20.3 Cr (+0.55% pts)
- Apollo Hospitals Enterprise Limitedup ₹16.8 Cr (+0.46% pts)
- Pfizer Limited ₹10 Cr (+0.27% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jan 2026, the weight rose most in Pharmaceuticals & Biotechnology (+0.6 pts), and fell most in Healthcare Services (−0.4 pts) and Pharmaceuticals (−0.3 pts).
- Pharmaceuticals & Biotechnology62.5% → 63.1%+0.6 pts
- Healthcare Services20.0% → 19.6%−0.4 pts
- Pharmaceuticals4.6% → 4.3%−0.3 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Feb 2023 | Feb 2025 | Aug 2025 | Nov 2025 | Jan 2026 | Feb 2026 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 68.0% | 65.2% | 67.3% | 64.5% | 62.5% | 63.1% |
| Healthcare Services | 16.8% | 17.5% | 17.5% | 17.8% | 20.0% | 19.6% |
| Healthcare Equipment & Supplies | 5.8% | 10.1% | 7.7% | 10.5% | 10.9% | 10.9% |
| Pharmaceuticals | 6.0% | 5.3% | 5.5% | 5.2% | 4.6% | 4.3% |
| Insurance | 2.3% | 1.4% | 1.5% | 1.5% | 1.5% | 1.5% |
| Retailing | 1.1% | 0.5% | 0.5% | 0.5% | 0.5% | 0.5% |
Allocation in Feb 2026change vs Jan 2026
- Pharmaceuticals & Biotechnology (15)63.1%▲ 0.6 pts
- Healthcare Services (7)19.6%▼ 0.4 pts
- Healthcare Equipment & Supplies (3)10.9%
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Feb 2026
1.1%
▼ 0.1 pts vs Jan 2026
- Cash alone
- 1.1%
- cash and net receivables
- A year earlier
- 1.7%
- Feb 2025 · now ▼ 0.7 pts
- Last 12 months
- 0.1% – 2.2%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.